Fmr LLC Rhythm Pharmaceuticals, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Fmr LLC holds 27,989 shares of RYTM stock, worth $1.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,989

Previous 29,020 3.55%

Holding current value

$1.54 Million

Previous $1.26 Million 8.59%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$35.41 - $44.37 $36,507 - $45,745	-1,031 Reduced 3.55%	27,989 $1.15 Million
Q1 2024 May 13, 2024	SELL	$39.12 - $52.44 $19.6 Million - $26.2 Million	-500,110 Reduced 94.52%	29,020 $1.26 Million
Q4 2023 Feb 13, 2024	SELL	$21.39 - $49.64 $7.26 Million - $16.8 Million	-339,344 Reduced 39.07%	529,130 $24.3 Million
Q3 2023 Nov 13, 2023	BUY	$15.81 - $27.8 $2.64 Million - $4.64 Million	166,940 Added 23.8%	868,474 $19.9 Million
Q2 2023 Aug 11, 2023	BUY	$16.32 - $21.15 $44,227 - $57,316	2,710 Added 0.39%	701,534 $11.6 Million
Q1 2023 May 11, 2023	SELL	$16.88 - $34.24 $1.25 Million - $2.54 Million	-74,204 Reduced 9.6%	698,824 $12.5 Million
Q4 2022 Feb 13, 2023	SELL	$22.21 - $30.25 $13.3 Million - $18.1 Million	-597,920 Reduced 43.61%	773,028 $22.5 Million
Q3 2022 Nov 10, 2022	BUY	$4.3 - $30.85 $3.5 Million - $25.1 Million	813,954 Added 146.13%	1,370,948 $33.6 Million
Q2 2022 Aug 12, 2022	BUY	$3.12 - $12.25 $9,756 - $38,305	3,127 Added 0.56%	556,994 $2.31 Million
Q1 2022 May 13, 2022	BUY	$6.13 - $12.24 $46,263 - $92,375	7,547 Added 1.38%	553,867 $6.38 Million
Q4 2021 Feb 14, 2022	BUY	$8.62 - $13.9 $3.99 Million - $6.44 Million	463,042 Added 556.02%	546,320 $5.45 Million
Q2 2021 Aug 13, 2021	BUY	$18.52 - $22.55 $1.54 Million - $1.88 Million	83,278 New	83,278 $1.63 Million

Others Institutions Holding RYTM

# of Institutions

178

Shares Held

69.1M

Call Options Held

467K

Put Options Held

224K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.06B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account